Six Swiss Exchange keen to attract Indian bioscience firms
This article was originally published in Scrip
Executive Summary
Six Swiss Exchange, a leading European bourse for life science companies, has initiated meetings with a clutch of Indian firms including pure play pharmaceutical, biotech and medical technology operations that may be eyeing a foreign listing or planning to raise capital through its platform.